GNRH1 and benign prostatic hyperplasia: We evaluated the effects of the GH-RH antagonist JMR-132 (40 μg daily), the LH-RH antagonist cetrorelix (0.625 mg/kg), and their combination on testosterone-induced BPH in adult male Wistar rats in vivo92.